News
A CDC advisory panel vote to recommend against use of seasonal influenza vaccines containing small amounts of thimerosal ...
A slower ramp-up of Kisunla dosing lowers the rate of dangerous brain swelling, a risk that has made doctors reluctant to ...
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
By Robin Respaut and Maggie Fick SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer. Each week the mother of two injects herself ...
16d
Dagens.com on MSNInside the DIY World of ‘Dangerous & Homemade’ Weight-Loss DrugsFaced with soaring prices and limited access to obesity medications, a growing number of Americans are taking matters into their own hands — literally. Across the country, people are importing drug ...
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...
Vial adaptors for reconstitution drugs play a critical role in chronic diseases, being used to safely and efficiently reconstitute and administer biologic or lyophilized medications often required ...
The healthcare professional administering Botox will reconstitute the medication by drawing up the proper amount of saline in a syringe and slowly injecting it into the vial of Botox.
Arguing that “preventing polypharmacy and medication mismanagement is a crucial focus, because the benefits of taking medication must outweigh the potential harms”, McKenzie said.
Research shows that NRTIs, antiviral drugs used for HIV, could prevent Alzheimer's by blocking inflammasomes, offering a promising path for drug repurposing.
Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted approval for 100 mg/10mL multi-dose vial of ...
Shorla Oncology Announces FDA Approval of TEPYLUTE® 100mg, First and Only Ready-to-Dilute Multi-Dose Vial of Thiotepa to Treat Breast and Ovarian Cancer and Commercial Launch of TEPYLUTE 15mg and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results